Novo CEO pressed by Senate to chop prices of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would think about new talks with insurers with regards to the list selling prices of Wegovy and copyright if they pledge to help keep the medicines on their formularies. https://buschpeachcalories59493.qodsblog.com/30653144/5-simple-techniques-for-healthcare-news